Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.1 USD | +1.28% | +4.41% | +5.97% |
Mar. 26 | North American Morning Briefing : Markets Steady -2- | DJ |
Mar. 25 | GoodRx Shares Jump Following Wells Fargo Upgrade, Price Target Boost | MT |
Financials (USD)
Sales 2024 * | 801M | Sales 2025 * | 857M | Capitalization | 2.77B |
---|---|---|---|---|---|
Net income 2024 * | 40M | Net income 2025 * | 85M | EV / Sales 2024 * | 3.34 x |
Net cash position 2024 * | 97.9M | Net cash position 2025 * | 382M | EV / Sales 2025 * | 2.79 x |
P/E ratio 2024 * |
86.4
x | P/E ratio 2025 * |
40.5
x | Employees | 694 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 19.91% |
Latest transcript on GoodRx Holdings, Inc.
1 day | +1.28% | ||
1 week | +4.41% | ||
Current month | -8.86% | ||
1 month | +7.74% | ||
3 months | +9.06% | ||
6 months | +30.04% | ||
Current year | +5.97% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Wagner
CEO | Chief Executive Officer | 53 | 23-04-24 |
Trevor Bezdek
FOU | Founder | 46 | 11-08-31 |
Douglas Hirsch
FOU | Founder | 53 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Agnes Rey-Giraud
BRD | Director/Board Member | 59 | 16-05-31 |
Dipanjan Deb
BRD | Director/Board Member | 54 | 15-09-30 |
Greg Mondre
BRD | Director/Board Member | 49 | 18-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.23% | 9 M€ | +22.75% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 7.1 | +1.28% | 1,016,625 |
24-03-27 | 7.01 | -0.71% | 1,238,611 |
24-03-26 | 7.06 | -0.14% | 1,394,413 |
24-03-25 | 7.07 | +7.45% | 2,627,578 |
24-03-22 | 6.58 | -2.52% | 460,443 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.97% | 2.77B | |
+3.47% | 360B | |
+24.74% | 266B | |
+25.04% | 163B | |
+21.17% | 106B | |
+7.75% | 77.53B | |
+39.27% | 56.11B | |
+40.44% | 51.6B | |
+10.54% | 39.3B | |
+7.34% | 31.13B |